Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04054505
Other study ID # EZ102018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2, 2019
Est. completion date January 4, 2021

Study information

Verified date January 2021
Source Optimal Health Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to correlate the findings of an early study with current data.


Recruitment information / eligibility

Status Completed
Enrollment 275
Est. completion date January 4, 2021
Est. primary completion date December 28, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 26 Years to 75 Years
Eligibility Inclusion Criteria: Healthy volunteers whose circulating serum vitamin A1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF-1 and FT-3 are within normal limits. A1; 48-85 ug/dl, E; 5.3-17.5 mg/L, B1; 66.5-200 nmo/L, B2; 137-370 ug/L, B6; 2-32.8 ug/L, B12; 211-946 pg/mL, C; 0.2-2.0 mg/dL, D; 30-100 ng/mL, Calcium; 8.7-10.2 mg/dL, Iron; 27-159 ug/dL, IGF-1; 67-205 ng/mL, FT-3; 2-4.4 pg/mL Exclusion Criteria: Volunteers whose circulating serum vitamin A1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3 are outside normal limits. A1; 48-85 ug/dl, E; 5.3-17.5 mg/L, B1; 66.5-200 nmo/L, B2; 137-370 ug/L, B6; 2-32.8 ug/L, B12; 211-946 pg/mL, C; 0.2-2.0 mg/dL, D; 30-100 ng/mL, Calcium; 8.7-10.2 mg/dL, Iron; 27-159 ug/dL, IGF-1; 67-205 ng/mL, FT-3; 2-4.4 pg/mL -

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
EZPAK
One packet with breakfast for three months
Placebo
One packet with breakfast for three months

Locations

Country Name City State
United States Optimal Health Research Salt Lake City Utah

Sponsors (1)

Lead Sponsor Collaborator
Optimal Health Research

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Raise in Circulating Serum Vitamin A1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3. Effectiveness of EZPAK in Raising Circulating Serum Levels Three months
Secondary Control group Levels of Circulating Serum VitaminA1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3. Three months
Secondary Placebo group Levels of Circulating Serum VitaminA1, E, B1,B2,B6,B12,C,D, Calcium, Iron, IGF and FT-3. Three months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03146273 - Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule) N/A
Completed NCT04587076 - Evaluation of Protein Intake and Micronutrient Supplementation After Bariatric Surgery
Completed NCT01653353 - Swiss Study on Vitamin D and Calcium in Nursing Homes N/A
Completed NCT01609387 - Postoperative Vitamin Supplementation in Morbidly Obese Patient (VITAAL Study) Phase 4
Not yet recruiting NCT06372366 - Relationship Between Vitamins Deficiency and Caries Experience Among a Group of Egyptian Children
Recruiting NCT03004807 - Role of Centrum® Silver® in Improving Micronutrient Status in Older Men N/A
Completed NCT04673721 - PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health N/A
Completed NCT01263288 - Effect of Vitamin D Supplementation on Muscular Strength, Musculoskeletal Pain and Headache Phase 4
Completed NCT03360435 - Absorption of Transdermal Vitamins in Post Bariatric Surgery Patients
Active, not recruiting NCT02272842 - Vitamin B12, Neurodevelopment and Growth in Nepal Phase 2/Phase 3
Not yet recruiting NCT06323538 - Cohort Study on Plant-based Diets (COPLANT Study)